These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35282751)

  • 21. Characteristics and outcomes of placenta accreta spectrum in twins versus singletons: a study from the Pan American Society for Placenta Accreta Spectrum (PAS
    Shamshirsaz AA; Carusi D; Shainker SA; Einerson B; Khandelwal M; Erfani H; Shamshirsaz AA; Modest AM; Aalipour S; Fox KA; Lyell DJ; Belfort MA; Silver RM
    Am J Obstet Gynecol; 2020 Jun; 222(6):624-625. PubMed ID: 31981509
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of placenta previa with placenta accreta spectrum disorder on fetal growth.
    Jauniaux E; Dimitrova I; Kenyon N; Mhallem M; Kametas NA; Zosmer N; Hubinont C; Nicolaides KH; Collins SL
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):643-649. PubMed ID: 30779235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First-trimester ultrasound diagnostic features of placenta accreta spectrum in low-implantation pregnancy.
    Abinader RR; Macdisi N; El Moudden I; Abuhamad A
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):457-464. PubMed ID: 34837427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Special Report of the Society for Maternal-Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum.
    Shainker SA; Coleman B; Timor-Tritsch IE; Bhide A; Bromley B; Cahill AG; Gandhi M; Hecht JL; Johnson KM; Levine D; Mastrobattista J; Philips J; Platt LD; Shamshirsaz AA; Shipp TD; Silver RM; Simpson LL; Copel JA; Abuhamad A;
    Am J Obstet Gynecol; 2021 Jan; 224(1):B2-B14. PubMed ID: 33386103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of first-trimester ultrasound in prediction of third-trimester sonographic stage of placenta accreta spectrum disorder and surgical outcome.
    Calí G; Timor-Tritsch IE; Forlani F; Palacios-Jaraquemada J; Monteagudo A; Kaelin Agten A; Flacco ME; Khalil A; Buca D; Manzoli L; Liberati M; D'Antonio F
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):450-459. PubMed ID: 31788885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of placental location in cases of placenta accreta spectrum.
    Morgan EA; Sidebottom A; Vacquier M; Wunderlich W; Loichinger M
    Am J Obstet Gynecol; 2019 Oct; 221(4):357.e1-357.e5. PubMed ID: 31344349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placenta Accreta Spectrum: Prenatal Diagnosis and Management.
    Horgan R; Abuhamad A
    Obstet Gynecol Clin North Am; 2022 Sep; 49(3):423-438. PubMed ID: 36122977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of placenta previa accreta: a systematic review and meta-analysis.
    Jauniaux E; Grønbeck L; Bunce C; Langhoff-Roos J; Collins SL
    BMJ Open; 2019 Nov; 9(11):e031193. PubMed ID: 31722942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What we know about placenta accreta spectrum (PAS).
    Liu X; Wang Y; Wu Y; Zeng J; Yuan X; Tong C; Qi H
    Eur J Obstet Gynecol Reprod Biol; 2021 Apr; 259():81-89. PubMed ID: 33601317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interobserver agreement in MRI assessment of severity of placenta accreta spectrum disorders.
    Finazzo F; D'antonio F; Masselli G; Forlani F; Palacios-Jaraquemada J; Minneci G; Gambarini S; Timor-Tritsch I; Prefumo F; Buca D; Liberati M; Khalil A; Cali G
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):467-473. PubMed ID: 31237043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update of diagnostic efficacy of ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders.
    Fratelli N; Fichera A; Prefumo F
    Curr Opin Obstet Gynecol; 2022 Oct; 34(5):287-291. PubMed ID: 35895953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of interventional radiology in pregnancy complicated by placenta accreta spectrum disorder: systematic review and meta-analysis.
    D'Antonio F; Iacovelli A; Liberati M; Leombroni M; Murgano D; Cali G; Khalil A; Flacco ME; Scutiero G; Iannone P; Scambia G; Manzoli L; Greco P
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):743-751. PubMed ID: 30255598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Ultrasound and MRI in Diagnosis of Severe Placenta Accreta Spectrum Disorder: An Intraindividual Assessment With Emphasis on Placental Bulge.
    Thiravit S; Ma K; Goldman I; Chanprapaph P; Jha P; Hippe DS; Dighe M
    AJR Am J Roentgenol; 2021 Dec; 217(6):1377-1388. PubMed ID: 34037411
    [No Abstract]   [Full Text] [Related]  

  • 34. Placenta Accreta Spectrum Prenatal Diagnosis Performance: Are Ultrasound False-positive Results Acceptable in Limited-resources Settings?
    Nieto-Calvache AJ; Benavides-Calvache JP; Hidalgo A; Padilla N; López-Tenorio J; Victoria A; Rengifo M; Mejía M; Vergara-Galliadi LM; Sinisterra-Díaz SE; Maya J; Zambrano MA; Burgos-Luna JM
    Rev Bras Ginecol Obstet; 2022 Sep; 44(9):838-844. PubMed ID: 36067797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasound accuracy in prenatal diagnosis of abnormal placentation of posterior placenta previa.
    Garofalo A; Pilloni E; Alemanno MG; Garofalo G; Sciarrone A; Todros T; Viora E
    Eur J Obstet Gynecol Reprod Biol; 2019 Nov; 242():86-91. PubMed ID: 31574389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders.
    Einerson BD; Rodriguez CE; Kennedy AM; Woodward PJ; Donnelly MA; Silver RM
    Am J Obstet Gynecol; 2018 Jun; 218(6):618.e1-618.e7. PubMed ID: 29572089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic accuracy of ultrasound in the diagnosis of Placenta accreta spectrum: systematic review and meta-analysis.
    Maged AM; El-Mazny A; Kamal N; Mahmoud SI; Fouad M; El-Nassery N; Kotb A; Ragab WS; Ogila AI; Metwally AA; Lasheen Y; Fahmy RM; Katta M; Shaeer EK; Salah N
    BMC Pregnancy Childbirth; 2023 May; 23(1):354. PubMed ID: 37189095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.
    Hussein AM; Elbarmelgy RA; Elbarmelgy RM; Thabet MM; Jauniaux E
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):474-482. PubMed ID: 34225385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical utility of magnetic resonance imaging as an adjunct to ultrasound in the diagnosis of placenta accreta spectrum disorders.
    Rekawek P; Liu L; Pan S; Overbey J; Wagner B
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6008-6012. PubMed ID: 33771092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scoring system for the prediction of the severity of placenta accrete spectrum in women with placenta previa: a prospective observational study.
    Luo L; Sun Q; Ying D; Wu X; Yan P; Yang Y; Chen Z
    Arch Gynecol Obstet; 2019 Sep; 300(3):783-791. PubMed ID: 31250197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.